ObvioHealth is a global digital health organization providing real-world digital studies that deliver better data.
ObvioHealth is on a mission to help people through research.
ObvioHealth was founded in 2015 by Ivan Jarry. The company is headquartered in Orlando, Florida, with offices in Switzerland, Singapore and Australia.
ObvioHealth developed and launched one of the first patient-centric apps, downloadable on smartphones, enabling people to participate in clinical trials from the comfort of their homes and empowering its virtual team to communicate directly with patients, wherever they are, to provide support and assistance throughout their trials.
ObvioHealth's mobile clinical study application allows for site-less trial design, allowing subjects to use their smartphones to participate in remote monitoring clinical trials from the comfort of their homes.
ObvioHealth is backed by Dedalus Group, SPRIM Global Investments, Novotech Health, and AT Capital Group. The company raised $31M in Series B round on Jul 01, 2021. This brings ObvioHealth's total funding to $51M to date.
